A Non-dispensing Fit Evaluation of Investigational Limbal Ring Soft Contact Lenses With Polyvinylpyrrolidone (PVP) in Asian Eyes

NCT ID: NCT02036320

Last Updated: 2018-06-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

190 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Study Completion Date

2014-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical trial is to compare the overall lens fit acceptance of two different soft contact lenses in an Asian population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vision Correction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

etafilcon A with additive printed limbal ring

Each subject will insert the trial lens while being observed by a technician prior to assessment by the study investigator.

Group Type EXPERIMENTAL

etafilcon A

Intervention Type DEVICE

Each study subject will be exposed to both test lenses following a washout period of five minutes between test periods.

etafilcon A

Each subject will insert the trial lens while being observed by a technician prior to assessment by the study investigator.

Group Type ACTIVE_COMPARATOR

etafilcon A

Intervention Type DEVICE

Each study subject will be exposed to both test lenses following a washout period of five minutes between test periods.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

etafilcon A

Each study subject will be exposed to both test lenses following a washout period of five minutes between test periods.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The subject must read, understand, and sign the statement of informed consent and receive a fully executed copy of the form.
2. The subject must appear able and willing to adhere to the instructions set forth in the clinical protocol.
3. The subject must be an Asian female (self-reported).
4. The subject must be at least 18 years old and less than 41 years old.
5. The subject must meet two of the four East Asian anatomical categories (Appendix D) and have a prominent epicanthic fold to be classified East Asian ethnicity. For the purpose of this protocol, East Asian ethnicities may include: China, Japan, Korea, Taiwan, Vietnam, Hong Kong, Malaysia, and Singapore but are not inclusive of these regions.
6. The subject must be a habitual soft contact lens wearer. Habitual is defined as: at least one month of daily wear where the lenses are worn a minimum of six (6) hours per day and a minimum of three (3) days per week prior to enrollment in the study.
7. The subject's optimal non-vertexed spherical equivalent distance correction (based on their optimal sphero-cylinder refraction) must be between +2.00 D and -12.00 D.
8. Any cylinder power must be less than or equal to -1.00 D confirmed by refraction.
9. The subject must possess a functional/usable pair of spectacles and wear them to the visit (only if applicable-to the investigator's discretion).
10. The subject's best correctable visual acuity is 20/40 or better (OD and OS) at the baseline visit.

Exclusion Criteria

1. Ocular or systemic allergies which might interfere with contact lens wear.
2. Ocular or systemic disease which might interfere with contact lens wear.
3. Any known hypersensitivity or allergic reaction to contact lenses or contact lens solutions.
4. Use of any ocular or topical medication.
5. Use of any systemic (oral) medication that is taken for an ocular condition which might interfere with contact lens wear.
6. Use of any systemic (oral) medication that is taken for a systemic condition which might interfere with the contact lens wear (this determination will be at the discretion of the investigator).
7. Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities, bulbar injection or any other abnormalities of the cornea and/or conjunctiva which would contraindicate contact lens wear.
8. Rigid gas permeable or hybrid design (rigid gas permeable center and a soft lens skirt) contact lens wear within the past 30 days.
9. Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, or aphakia.
10. Any previous or planned (during duration of the study), ocular or intraocular surgery (e.g. radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), peripheral iridotomy, etc.)
11. Pregnancy or lactation.
12. Diabetes.
13. Infectious disease.
14. Habitual contact lens type is multifocal, monovision or worn as extended wear.
15. Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment.
16. Suspicion of or recent history od alcohol or substance abuse.
17. History of serious mental illness.
18. History of seizures.
19. Employee or family member of the investigational clinic (e.g. Investigator, Coordinator, Technician).
Minimum Eligible Age

18 Years

Maximum Eligible Age

41 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johnson & Johnson Vision Care, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Berkeley, California, United States

Site Status

Fullerton, California, United States

Site Status

New York, New York, United States

Site Status

Cleveland, Ohio, United States

Site Status

Dallas, Texas, United States

Site Status

Houston, Texas, United States

Site Status

Waterloo, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CR-5477

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.